Evaluation of minimum detection limit to hepatitis B virus (HBV) PCR “nested
Autor(a) principal: | |
---|---|
Data de Publicação: | 2008 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Clinical and Biomedical Research |
Texto Completo: | https://seer.ufrgs.br/index.php/hcpa/article/view/2945 |
Resumo: | All over the world, the hepatitis B virus (HBV) is considered one of the major problems of public health, despite vaccination. World Health Organization (WHO) estimates that more than 2 billions of persons are infected by HBV. Brazil is classified as an area of intermediary incidence by WHO. However, prevalence studies have detected differences of infection indexes in geographic re-gions: 8% in the Amazonian region, 2,5% in middle-west and Northeast, 2% in Southeast and 1% in South. A sensitive and specific diagnosis is very important to the HBV carrier patients. The aim of this study was to determine the minimum limit of detection of the nested PCR in house technique for HBV. Serial dilutions of one quantified sample of HBV (1000 copies/mL; 750 copies/mL; 500 copies/mL; 250 copies/mL) were submitted to a nested PCR. The target of PCR was viral core and pre-core region. Commercial kit, QiAmp, was employed to purify nucleic acids from the sample. The minimum detection limit found was 500 copies/mL or 10 copies per PCR reaction. |
id |
UFRGS-20_4a1dc62cbfe0de91a2044a386c4ab910 |
---|---|
oai_identifier_str |
oai:seer.ufrgs.br:article/2945 |
network_acronym_str |
UFRGS-20 |
network_name_str |
Clinical and Biomedical Research |
repository_id_str |
|
spelling |
Evaluation of minimum detection limit to hepatitis B virus (HBV) PCR “nestedDeterminação do Limite Mínimo de Detecção da Técnica de PCR “Nested” para o Vírus da Hepatite B (HBV)HBVPCRHepatite BHepatite BAll over the world, the hepatitis B virus (HBV) is considered one of the major problems of public health, despite vaccination. World Health Organization (WHO) estimates that more than 2 billions of persons are infected by HBV. Brazil is classified as an area of intermediary incidence by WHO. However, prevalence studies have detected differences of infection indexes in geographic re-gions: 8% in the Amazonian region, 2,5% in middle-west and Northeast, 2% in Southeast and 1% in South. A sensitive and specific diagnosis is very important to the HBV carrier patients. The aim of this study was to determine the minimum limit of detection of the nested PCR in house technique for HBV. Serial dilutions of one quantified sample of HBV (1000 copies/mL; 750 copies/mL; 500 copies/mL; 250 copies/mL) were submitted to a nested PCR. The target of PCR was viral core and pre-core region. Commercial kit, QiAmp, was employed to purify nucleic acids from the sample. The minimum detection limit found was 500 copies/mL or 10 copies per PCR reaction.Mundialmente, a hepatite pelo vírus B (HBV) é considerada um dos maiores problemas de saúde pública, apesar da vacina-ção. A Organização Mundial da Saúde (OMS) estima que mais de 2 bilhões de pessoas estejam infectadas pelo HBV. O Brasil é classificado como área de incidência intermediária pela OMS. No entanto, estudos de prevalência detectaram diferenças de índices de infecção nas regiões geográficas: 8% na região Amazônica, 2,5% nas regiões Centro-Oeste e Nordeste, 2% na Sudeste e 1% na região Sul. Um diagnóstico sensível e específico é de fundamental importância para os pacientes portadores do HBV. O objetivo deste estudo foi determinar o limite mínimo de detecção da técnica de PCR “nested” “in house” para o HBV. Diluições seriadas de uma amostra quantificada de HBV (1000 cópias/mL; 750 cópias/mL; 500 cópias/mL; 250 cópias/mL) foram submetidas à técnica de PCR “nested”. O alvo da amplificação por PCR foi a região do core e pré-core do vírus. Para extração dos ácidos nucléicos da amostra foi empregado o kit comercial QIAmp. O limite mínimo de detecção encontrado foi de 500 cópias/mL ou 10 cópias por reação de PCR.HCPA/FAMED/UFRGS2008-06-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed ArticleAvaliado por Paresapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/2945Clinical & Biomedical Research; Vol. 28 No. 1 (2008): Revista HCPAClinical and Biomedical Research; v. 28 n. 1 (2008): Revista HCPA2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSporhttps://seer.ufrgs.br/index.php/hcpa/article/view/2945/2531Coser, Tiago BottinChesky, Marisade-Paris, FernandaBarth, Afonso LuisSchmitt, Virginia MinghelliPinheiro Machado, Alice Beatriz Mombachinfo:eu-repo/semantics/openAccess2020-01-16T16:15:43Zoai:seer.ufrgs.br:article/2945Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2020-01-16T16:15:43Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.none.fl_str_mv |
Evaluation of minimum detection limit to hepatitis B virus (HBV) PCR “nested Determinação do Limite Mínimo de Detecção da Técnica de PCR “Nested” para o Vírus da Hepatite B (HBV) |
title |
Evaluation of minimum detection limit to hepatitis B virus (HBV) PCR “nested |
spellingShingle |
Evaluation of minimum detection limit to hepatitis B virus (HBV) PCR “nested Coser, Tiago Bottin HBV PCR Hepatite B Hepatite B |
title_short |
Evaluation of minimum detection limit to hepatitis B virus (HBV) PCR “nested |
title_full |
Evaluation of minimum detection limit to hepatitis B virus (HBV) PCR “nested |
title_fullStr |
Evaluation of minimum detection limit to hepatitis B virus (HBV) PCR “nested |
title_full_unstemmed |
Evaluation of minimum detection limit to hepatitis B virus (HBV) PCR “nested |
title_sort |
Evaluation of minimum detection limit to hepatitis B virus (HBV) PCR “nested |
author |
Coser, Tiago Bottin |
author_facet |
Coser, Tiago Bottin Chesky, Marisa de-Paris, Fernanda Barth, Afonso Luis Schmitt, Virginia Minghelli Pinheiro Machado, Alice Beatriz Mombach |
author_role |
author |
author2 |
Chesky, Marisa de-Paris, Fernanda Barth, Afonso Luis Schmitt, Virginia Minghelli Pinheiro Machado, Alice Beatriz Mombach |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Coser, Tiago Bottin Chesky, Marisa de-Paris, Fernanda Barth, Afonso Luis Schmitt, Virginia Minghelli Pinheiro Machado, Alice Beatriz Mombach |
dc.subject.por.fl_str_mv |
HBV PCR Hepatite B Hepatite B |
topic |
HBV PCR Hepatite B Hepatite B |
description |
All over the world, the hepatitis B virus (HBV) is considered one of the major problems of public health, despite vaccination. World Health Organization (WHO) estimates that more than 2 billions of persons are infected by HBV. Brazil is classified as an area of intermediary incidence by WHO. However, prevalence studies have detected differences of infection indexes in geographic re-gions: 8% in the Amazonian region, 2,5% in middle-west and Northeast, 2% in Southeast and 1% in South. A sensitive and specific diagnosis is very important to the HBV carrier patients. The aim of this study was to determine the minimum limit of detection of the nested PCR in house technique for HBV. Serial dilutions of one quantified sample of HBV (1000 copies/mL; 750 copies/mL; 500 copies/mL; 250 copies/mL) were submitted to a nested PCR. The target of PCR was viral core and pre-core region. Commercial kit, QiAmp, was employed to purify nucleic acids from the sample. The minimum detection limit found was 500 copies/mL or 10 copies per PCR reaction. |
publishDate |
2008 |
dc.date.none.fl_str_mv |
2008-06-03 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer-reviewed Article Avaliado por Pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://seer.ufrgs.br/index.php/hcpa/article/view/2945 |
url |
https://seer.ufrgs.br/index.php/hcpa/article/view/2945 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://seer.ufrgs.br/index.php/hcpa/article/view/2945/2531 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
HCPA/FAMED/UFRGS |
publisher.none.fl_str_mv |
HCPA/FAMED/UFRGS |
dc.source.none.fl_str_mv |
Clinical & Biomedical Research; Vol. 28 No. 1 (2008): Revista HCPA Clinical and Biomedical Research; v. 28 n. 1 (2008): Revista HCPA 2357-9730 reponame:Clinical and Biomedical Research instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Clinical and Biomedical Research |
collection |
Clinical and Biomedical Research |
repository.name.fl_str_mv |
Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
||cbr@hcpa.edu.br |
_version_ |
1799767051253841920 |